Gilead Sciences to Present at the Oppenheimer 20th Annual Healthcare Conference on Tuesday, November 3
Business Wire
Oct 30, 2009
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its corporate
presentation will be webcast from the Oppenheimer 20th Annual
Healthcare Conference in New York.
Patrick O’Brien, Gilead’s Director, Investor Relations, will provide an
overview of the company on Tuesday, November 3 at 10:50 a.m. Eastern
Time.
To access the live webcast or a replay via the internet log on to www.gilead.com.
Please connect to the company’s website at least 15 minutes prior to the
start of the presentation to ensure adequate time for any software
download that may be necessary to listen to the webcast. The replay will
be available for 14 days following the presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases worldwide. Headquartered in Foster City,
California, Gilead has operations in North America, Europe and Australia.
For more information on Gilead Sciences, please visit www.gilead.com
or call the Gilead Public Affairs Department at 1-800-GILEAD-5
(1-800-445-3235).
(c) 2009 Business Wire, Inc., All rights reserved. All of the news releases and other content contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. Any copying or reproduction (other than for an individual user's personal reference), redistribution, reposting or other transmission or communication is expressly prohibited without prior written permission of Business Wire, Inc
